1. Bokarev I. N., Kondrat'eva T. B. Novye oral'nye antikoagulyanty v klinicheskoi praktike. Effektivnost' i problemy. Klinicheskaya meditsina. 2016; 94 (5): 383–387. DOI: 10.18821/0023–2149–2016–94–5–383–387.
2. Bokeriya L. A., Zatevakhin I. I., Kirienko A. I. i soavt. Rossiiskie klinicheskie rekomendatsii po diagnostike, lecheniyu i profilaktike venoznykh tromboembolicheskikh oslozhnenii (VTEO). Flebologiya. 2015; 4 (2): 1–52.
3. Novikova N. A., Volovchenko A. N., Oldakovskii V. I. Gastroenterologicheskie oslozhneniya antikoagulyantnoi terapii u bol'nykh s neklapannoi fibrillyatsiei predserdii // Eksperimental'naya i klinicheskaya astroenterologiya. 2015; № 6 (118).
4. Kropacheva E. S., Zemlyanskaya O. A., Panchenko E. P., Dobrovol'skii A. B., Krivosheeva E. N. Bezopasnost' dlitel'noi terapii varfarinom: chastota krovotechenii i prediktory ikh razvitiya (rezul'taty prospektivnogo 15-letnego nablyudeniya). Aterotromboz. 2017 (1): 145–162. https://doi.org/10.21518/2307–1109–2017–1–28–32.
5. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleedingand Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real life setting. Am J Gastroenterol 2004; 99: 1238–46. DOI: 10.1111/j.1572–0241.2004.30272.x.